Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Atherosclerosis Article
This is a selection made from among articles on Drug Treatment Atherosclerosis. For a permanent link to this article, or to bookmark it for future reading, click here.
Definition of Drug Addiction
from:Even though drug addiction is a complex disease, assigning a definition for that disease is actually quite simple. Drug addiction is, in its simplest form, defined as the continued compulsive use of drugs in spite of adverse health or social consequences.
The definition of drug addiction should also include the fact that it is a state of heavy dependence on a specific drug. Generally, it’s thought of as a physical dependence, but in actuality, there is a psychological addiction as well as an emotional dependence. Some say that it is compulsive and pathological drug use or substance dependence.
Drug addiction is also a behavior disorder as the initial drug use is generally done as a reaction to a behavior or situation that seems out of control to the user. The user seems to have no other choice but to use that drug because of the body’s dependence on the fact that the drug will remain present in the system.
A distinction should be made between drug use and drug addiction. It is possible for people to use drugs without becoming addicted, but that is generally limited to prescription drug use. People who take drugs to cope with a physical ailment do so to control pain or the adverse effects of a physical condition. Those drugs improve the quality of life for the sufferer, but they are not necessarily addicted to the drugs.
To be dependent on a drug – or addicted to it – the user must take the drug regularly, and they experience unpleasant symptoms if they stop using the drug such as nausea or sleep disturbance. Substance abuse or addiction is present when a person uses a drug despite the harm that it causes to their system.
There is a difference between drug abuse and drug addiction. Drug abuse occurs when a person uses excessive amounts of a drug at one time or frequently. Drug addiction is present when a person cannot stop using the drug and stopping the drug seems like an impossibility.
Of course, no definition of drug addiction is complete without noting that it is both a physical dependence as well as a psychological one. Physical dependency occurs when a drug has been used habitually and the body has become accustomed to its effects. Psychological dependency is present when the drug is used habitually and the mind has become accustomed to the effects the drug produces.
When drug addiction affects a person’s life, the definition of that drug addiction becomes a bit less important than the reasons why people use. However, it can help multitudes if a definition is specified so that a better understanding of drug addiction can occur.
Drug Treatment Atherosclerosis Specific links
Drug Treatment Atherosclerosis News
Sanofi's cholesterol drug reports positive test results
PARIS (Reuters) - An experimental cholesterol treatment being jointly developed by Regeneron and Sanofi has shown it can lower bad cholesterol levels in difficult-to-treat patients, according to data from a mid-stage study published on Saturday. The treatment, a monoclonal antibody that works by blocking a protein called PCSK9 which preserves high bad cholesterol levels in the bloodstream, is a ...
Read more...Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
According to study results to be featured in Sunday’s late-breaking clinical trials session at the American Association of Clinical Endocrinologists 21st Annual Scientific and Clinical Congress in Philadelphia, the Resolute® drug-eluting stent from Medtronic, Inc.
Read more...CORRECTING and REPLACING Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical ...
Please replace the release with the following corrected version due to multiple revisions.
Read more...Studies of Medtronic IN.PACT Drug-Eluting Balloons Show Significant Benefit in Peripheral and Coronary Arteries
PARIS--(BUSINESS WIRE)--Physicians presented today at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the BELLO and PACIFIER studies, each one showing statistically significant advantages of using an IN.PACT drug-eluting balloon from Medtronic, Inc. (NYSE: MDT) over a corresponding conventional treatment for coronary and peripheral artery disease. Medtronic IN.PACT ...
Read more...Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
PARIS and TARRYTOWN, New York, May 26, 2012 /PRNewswire/ --Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase ...
Read more...Data for Amarin's AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions
BEDMINSTER, N.J. and DUBLIN, Ireland -- Amarin Corporation plc , a late-stage biopharmaceutical company focused on cardiovascular disease, today announced that additional data from the AMR101 pivotal Phase ...
Read more...Spherix Announces First Quarter 2012 Financial Results
BETHESDA, Md. -- Spherix Incorporated -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, ...
Read more...Dr Reddy's may launch low-cost copy of Plavix in US
Dr Reddy’s Laboratories may soon launch a low-cost version of blood thinning drug Plavix in the US, the world’s largest drug market.
Read more...Press Release
Medtronic Inc. Posted on:16 May 12 Physicians presented today at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the BELLO and PACIFIER studies, each one showing statistically significant advantages of using an IN.PACT drug-eluting balloon from Medtronic, Inc. (NYSE: MDT) over a corresponding conventional treatment for coronary and peripheral artery disease.
Read more...European expert presents new guidelines for cardio care
Global healthcare leader MSD invited guest speaker Alberico Catapano, chairman of the European Atherosclerosis Society (EAS), to deliver a lecture on the topic “New Advances in Cardiovascular Risk Reduction in High-Risk Patients” at the 17th Joint Annual Convention of the Philippine Society of Hypertension and Philippine Lipid and Atherosclerosis Society at the Crowne Plaza Hotel.
Read more...